Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0000899243-22-029072

Chief Executive Officer sold 20,350 shares at $0.68 ($13,838)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Barrow Robert Chief Executive Officer 2022-08-16 Sale −20,350 $0.68 $13,838 3,860,438 D
Open-market sales · 20,350 sh · avg $0.68 · $13,838
Loading xslF345X03/doc4.xml…